Abstract-Fibrinogen and platelets rapidly saturate the exposed subendothelium of a freshly deendothelialized aorta in vivo. As thrombin generated within the site of injury is largely responsible for fibrin(ogen) deposition, we questioned whether various anticoagulant treatments would inhibit uptake of both fibrinogen and platelets in vivo. Rabbits were anticoagulated by pretreatment with either Warfarin, Ancrod, or recombinant hirudin. Each anesthetized, anticoagulated (or saline-injected control) rabbit was injected IV with rabbit 51 Cr-platelets and 125 I-fibrinogen before a balloon-catheter deendothelializing (or sham) injury of the thoracic aorta. At 10 minutes after injury, the rabbit was exsanguinated and the aorta excised. Platelet adsorption by the deendothelialized aorta surface was substantially reduced in anticoagulated rabbits (controls, 2.2ϫ10 5 /mm 2 ; Warfarin-treated, 1.2ϫ10 5 /mm 2 ; Ancrod-treated, 5.3ϫ10 4 /mm 2 ; r-hirudin-treated [5 mg/kg], 5.3ϫ10 4 /mm 2 ), and a significant reduction of fibrinogen associated with the platelet layer (from 5.3 to 1 to 2 pmol/cm 2 ) and within the underlying intima-media layer (from 16.9 to 5 to 6 pmol/cm 2 ) was observed in the r-hirudin-and Warfarin-treated rabbits. The pattern of aorta-deposited 51 Cr-platelets and 125 I-fibrin in the anticoagulated rabbits corresponded well with an assessment by transmission electron microscopy of aortic tissue samples. We conclude that Ϸ70% of fibrinogen uptake is thrombin dependent and that Ϸ80% of platelet adsorption depends on codeposited fibrin(ogen) during the 10-minute interval after balloon injury. Pretreatment with an agent that interferes with either thrombin or fibrin production will inhibit the immediate interaction of fibrinogen and platelets with the freshly exposed subendothelium. (Arterioscler Thromb Vasc Biol. 1998;18:816-824.)
I n 1973, Baumgartner 1 showed that circulating platelets rapidly carpeted the deendothelialized surface of a rabbit aorta after an inflated balloon catheter had been drawn along the vessel lumen. The surface of the ballooned aorta was essentially saturated with platelets by 10 minutes after injury, although deposition of fibrin was not obvious. Later, Groves et al 2 quantified the deposition of 51 Cr-labeled platelets on the deendothelialized aortas of rabbits that at various times after balloon-catheter injury had been preperfused, first with a heparin-containing physiological solution and then with 4% glutaraldehyde to fix the tissue. These authors found that the exposed subendothelium was saturated by Ϸ45 000 platelets per square millimeter, which, when viewed by scanning electron microscopy, appeared as a monolayer, with most platelets spread on the vessel surface. Later, these authors 3 reported that heparin, administered (500 U/kg IV) 10 minutes before inducing a balloon-catheter injury, decreased slightly the accumulation of platelets at the exposed subendothelium in vivo, and Dejana et al 4 showed that heparin significantly prevented platelets from binding to the exposed subendothelium of the everted rabbit aorta segments rotated in vitro. In the latter study, it was concluded that thrombin was involved in the accumulation of platelets at the surface of the exposed subendothelium. Since then, several reports 5, 6 have identified thrombin as a primary agent responsible for platelets associating with the ballooned rabbit aorta surface and promoting platelet thrombus formation in vitro. These researchers have studied platelet behavior over a wide range of wall shear rates using a perfusion chamber technique. Recently, however, Gast et al 7 have concluded, from perfusion chamber experiments, that thrombin is not involved in platelet thrombus formation immediately after injury but is involved later in thrombogenesis on the exposed aortic subendothelium.
The behavior of plasma 125 I-fibrinogen has also been studied in rabbits after a balloon-catheter injury to the aorta. 8, 9 Fibrinogen saturated the deendothelialized aorta surface in vivo too rapidly (Ͻ5 minutes after injury) for a precise time curve to be measured. Subsequently, we demonstrated from studies in vitro that the quantity of fibrinogen bound by the exposed subendothelium was dependent directly on the amount of active thrombin associated with that surface. 10 Indeed, an enhanced uptake of fibrinogen was maintained throughout the reendothelialization process, an event that endured for at least 20 months in the rabbit aorta. 11 As fibrinogen supports the aggregation of thrombin-activated platelets, we questioned to what extent the deposition of plasma fibrinogen and the deposition of platelets at the ballooned aorta surface in vivo were interdependent. Is a single factor, namely thrombin, responsible for the deposition of both fibrinogen and platelets? In this study, we compare the uptake of fibrinogen with that of platelets over the first 10 minutes after balloon-catheter injury to the rabbit aorta in vivo using a quantitative and a morphological approach. An interval of 10 minutes between balloon injury and exsanguination was chosen because it allows sufficient time for saturation of the ballooned aorta by both fibrin(ogen) and platelets. As we are uncertain of the ratio of adsorbed fibrinogen and deposited fibrin by the aorta wall, we have referred to this material as fibrin(ogen). In addition, we have compared the adsorption of fibrin(ogen) and platelets to the deendothelialized aorta by using rabbits that had either not received an anticoagulant treatment or had been anticoagulated using one of four different procedures to discover any relationship that directly links these responses to injury. The chosen anticoagulants were recombinant hirudin, a highly specific thrombin inhibitor 12 ; Ancrod, which acts by effectively removing fibrinogen from the circulatory system; and Warfarin, which selectively inhibits production of active vitamin K-dependent proteins by the liver.
Methods

Preparation and Labeling of Rabbit Fibrinogen
Fibrinogen was isolated from ACD-anticoagulated 13 plasma from NZW rabbits using first a ␤-alanine precipitation method 14 and purified further by DEAE cellulose chromatography with a Ca 2ϩ -containing buffer system. 15 By these means, rabbit fibrinogen with Ͼ97% thrombin clottability was obtained. 8 Fibrinogen was radiolabeled using an Iodo-gen-coated glass vial 16 as follows: Ϸ100 g of protein (in 300 L 0.1 mol/L sodium phosphate, pH 7.4) was placed in a flat-bottomed glass vial previously coated with 5 g Iodo-Gen (Pierce Chemical Co) and containing a small (5 mm) stir bar. A 10-L vol (1 mCi) of [ 125 I]NaI (ICN Pharmaceuticals) was added and the reaction was allowed to progress for 2 minutes at room temperature.
125 I-fibrinogen was dialyzed for 18 hours against 4ϫ250 mL 0.01 mol/L sodium phosphate-buffered 0.15 mol/L NaCl, pH 7.4, at 4°C, stored at 4°C, and used for experiment within 4 days of labeling.
Preparations of rabbit fibrinogen and 125 I-fibrinogen were tested for purity before and after reduction by ␤-mercaptoethanol using PAGE in the presence of 0.1% SDS. 17 Plasma samples from some Ancrod-treated rabbits were analyzed for fibrinogen as follows. Unreduced diluted plasmas were electrophoresed using SDS-PAGE and the gel content was electroblotted to Immobilon (Millipore Corp). The blot was developed by using first a polyspecific antirabbit fibrinogen antibody (raised in a laying hen and isolated from egg yolks 18 ), followed by an alkaline phosphatase-linked antichicken IgG (Zymed Inc), and then an appropriate substrate, BCIP, and complexing agent, NBT (both obtained from BioRad). Reactive bands were scanned by using a Howteck Scanmaster "3ϩ" (Howteck Inc) and analyzed using BioImage Whole Band Analysis software (Millipore Corp). The fibrinogen content of rabbit plasma samples was determined quantitatively using an ELISA described previously.
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Anticoagulant Drugs
Warfarin (3-[␣-acetonylbenzyl]-4-hydroxycoumarin, Na salt) was purchased from Sigma Chemical Company. Ancrod (also known as "Arvin") was obtained from Knoll Pharma Inc as a sterile solution (70 IU/mL). Recombinant desulfato-hirudin (r-hirudin; CGP39393) was a gift from Ciba Pharmaceuticals (Horsham, Sussex, UK).
Preparation and 51 Cr Labeling of Rabbit Platelets
For each experiment that required 51 Cr-platelets, the platelet fraction, obtained from exsanguinated blood of a donor NZW rabbit (weight range 2.3 to 3.0 kg), was radiolabeled with 51 Cr before injecting into a second NZW rabbit (designated the experimental rabbit). Procedures used for isolating, washing, and radiolabeling platelets from freshly drawn, ACD-anticoagulated rabbit blood were described previously. 20, 21 After a fourth wash, the radiolabeled platelets were suspended in 10 mL of platelet-poor rabbit plasma. For Ancrodtreated rabbits, 51 Cr-labeled platelets were suspended in 10 mL of freshly prepared, Ancrod-treated rabbit plasma (after removal of the fibrin clot). Measurement of the 51 Cr-platelet count (before injection) was determined using a Coulter counter, and radioactivity content using a Minaxi-Autogamma 5000 counter (Canberra-Packard Ltd). The specific radioactivity (ie, number of platelets per 51 Cr count per minute) ranged between 2000 and 8000 platelets per cpm (mean: 4900Ϯ1385 platelets per cpm; nϭ40).
Anticoagulation of Rabbit Circulation
All proposals for experiments using NZW rabbits were first approved by the Animal Research Ethics Board (McMaster University) and were conducted within the guidelines recommended for recovery surgery by the Canadian Council on Animal Care. 22 Rabbits were injected (ear vein) with one of five anticoagulant treatments, ie, Warfarin, Ancrod, r-hirudin (low or high dose), or Ancrod followed by r-hirudin (low dose); control rabbits were injected with sterile saline. No serious bleeding complications were seen during or after any of the above treatments or during or after sample injections or balloon-catheter treatment.
Warfarin
Each rabbit was injected with Warfarin at 40 mg/kg, dissolved in sterile saline immediately before injection. The same dose was repeated 2 days later. Warfarin-treated rabbits were taken for balloon or sham injury on either day 4 or 5 after the start of Warfarin treatment. Blood samples (each Ϸ1 mL) were taken from an ear artery into 0.25 mL ACD before Warfarin was injected and again on day 4 (or 5) after the start of Warfarin treatment for measurement of the prothrombin time. The ratio of prothrombin clotting times, post-Warfarin plasma (mean, 24.6 seconds)/pre-Warfarin plasma (10.7 seconds), amounted to 2.3 (Ϯ0.3).
Ancrod
Rabbits were injected with Ancrod at 1 IU/kg. One hour after the first dose, each rabbit was given a second dose (1 IU/kg), and 2 hours after the first dose, a third dose (2 IU/kg) was given. The rabbit was then housed for 4 hours. At 6 hours after the start of Ancrod treatment, a blood sample was taken into a known volume of ACD and the rabbit was anesthetized in preparation for balloon or sham injury (see below). Platelet levels, taken before and after 6 hours of Ancrod treatment, were measured by CBC analysis of weighed blood samples (to determine the dilution by ACD) by the Section of Laboratory Medicine (Chedoke-McMaster Hospitals). Also, plasmas
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ACD ϭ acid citrate-dextrose ELISA ϭ enzyme-linked immunosorbent assay NZW ϭ New Zealand White PAGE ϭ polyacrylamide gel electrophoresis TEM ϭ transmission electron microscopy from the same blood samples were analyzed for fibrinogen content as described above.
r-Hirudin
r-Hirudin (used either as a low dose of 1.2Ϯ0.2 mg/kg, or a high dose of 5.0Ϯ0.2 mg/kg) was injected Ϸ3 minutes before the anesthetized rabbit was subjected to either a balloon or sham injury. Activated partial thromboplastin times were measured in a parallel series of experiments 23 on plasma samples taken from r-hirudintreated NZW rabbits (1 mg/kg) at 5 to 20 minutes after injection; activated partial thromboplastin times for control (ie, prehirudin) plasmas and posthirudin plasmas were 41.8Ϯ2.9 and 84.0Ϯ19.5 seconds, respectively.
Ancrod/r-Hirudin
Rabbits were treated with Ancrod as described above. Each rabbit was anesthetized at 6 hours after the start of Ancrod treatment. r-Hirudin (Ϸ1 mg/kg) was injected Ϸ3 minutes before the rabbit was subjected to a balloon-catheter injury.
Saline
Rabbits, after receiving a dose of anesthetic, were injected with 1 mL saline before balloon-catheter or sham injury.
Uptake of Platelets and Fibrinogen by the Aorta Wall Immediately After a Balloon-Deendothelializing Injury In Vivo
A blood sample was taken from the ear artery (Ϸ1 mL) of each NZW rabbit (range: 2.1 to 3.3 kg; mean: 2.6Ϯ0.3 kg) into 0.25 mL ACD, weighed, and measured for platelet content.
Rabbits were anesthetized by intravenous injection of sodium pentobarbital (up to 35 mg/kg). After shaving the front of the neck and inner thigh areas, a carotid artery was cannulated (PE 200 tubing) and a femoral artery isolated. At Ϸ15 minutes after inducing anesthesia, each r-hirudin-or Warfarin-treated rabbit was injected (through the carotid cannula) with Ϸ10 mL of 51 Cr-labeled platelets (containing 4 to 10ϫ10 6 cpm; mean: 6.0Ϯ1.5ϫ10 6 cpm). The line was then immediately flushed with 1 mL of sterile saline before injecting 1 mL of 125 I-fibrinogen (10 to 20ϫ10 6 cpm; 14.9Ϯ3.3ϫ10 6 cpm; 18.7Ϯ9.4 g) in sterile saline. Again, the line was flushed with 1 mL of sterile saline. All Ancrod-treated rabbits were injected only with 51 Cr-platelets followed by 1 mL of sterile saline. In all recipient rabbits, the proportion of 51 Cr-platelets added to the circulation was calculated from the specific radioactivity of the preparation of 51 Cr-platelets, using the known quantity of 51 Cr-platelets injected and the blood platelet count and weight (and hence the blood volume) of the recipient rabbit; the proportion of donor 51 Cr-platelets after injection amounted to 33.5Ϯ1.4% (nϭ40) of the total platelet population.
At 5 minutes after injection, a blood sample (carotid artery; 1 mL) was taken into 0.25 mL ACD and the rabbit was given either a deendothelializing injury or a sham injury to the thoracic aorta. For the balloon treatment, a Fogarty balloon catheter (Baxter Healthcare Corp; type 12-040-4F) was inserted into an exposed femoral artery and maneuvered into the aorta. The thoracic aorta was subjected to two passes with an expanded balloon volume (containing 1 mL of sterile saline) and the artery ligated as described previously. 9 For the sham-injury treatment, a femoral artery was ligated but not penetrated. A timer was started as the femoral artery was ligated. At 10 minutes after femoral ligation, a second blood sample was taken before the rabbit was rapidly exsanguinated through the carotid cannula. The chest was opened and the thoracic aorta isolated, flushed with 10 mL of BSA-minimum essential medium (with Earle's salts and L-glutamine), and then excised.
Adventitial fat was removed and the thoracic aorta divided into eight 1-cm-long segments (segment 1, arch end; segment 8, diaphragm end). Segment 4 from each aorta was placed into 4% (wt/vol) paraformaldehyde for TEM studies. The remaining segments were processed as follows: After measuring the surface area of each segment using a digital planimeter (Lasico), the luminal surface, which for sham-injured aortas included the endothelium and associated basement membrane 24 and for deendothelialized aortas included the platelet layer, 8 was stripped cleanly from the aorta using cellulose acetate paper as a Häutchen preparation. 25 The underlying subendothelium, referred to as the intima-media layer, was then stripped from the vessel wall using Bergh forceps. 26 The vessel layers of seven individual segments from each aorta were each placed in a plastic-capped vial (Biovial, Beckman) and measured for radioactivity content. The 125 I counts were corrected for crossover of 51 Cr into the 125 I channel. The corrected 125 I radioactivity per unit area, ie, cpm/cm 2 of aorta layer, was compared with the respective radioactivity content of 1 mL of blood at exsanguination. The quantity of bound fibrinogen per square centimeter was calculated assuming a hematocrit of 42% and a blood concentration of 3.58 mol/L fibrinogen 19 for a healthy NZW rabbit. By using the known proportion of 51 Cr-platelets in the circulation for each 51 Cr-platelet preparation and their specific radioactivity (ie, number of platelets per cpm), the mean number of adsorbed platelets per square millimeter could be calculated from the 51 Cr content of the cellulose acetate layer obtained from each of the seven 1-cm-length segments of each thoracic aorta.
Uptake of 125 I-Fibrinogen by the Aorta Wall During Exsanguination
Rabbits that had not received an anticoagulant treatment were anesthetized and a carotid cannula was inserted as described above. A balloon or sham injury was performed, and the clock was started at the moment of femoral ligation as the balloon (or sham) injury was completed. An intravenous dose of 125 I-fibrinogen (Ϸ19 g in 1 mL of sterile saline) was injected at either 7 minutes, 8 minutes, or 9 minutes after the clock was started. An intra-arterial blood sample (Ϸ2 mL into 0.5 mL ACD) was taken at 10 minutes, and the rabbit was exsanguinated immediately through the carotid cannula. The aorta was isolated, flushed with BSA-minimum essential medium Eagle, and excised as described above. The surface area and radioactivity content of the Häutchen preparation of the platelet layer (of balloon-injured aortas) or endothelium (of the sham-injured aortas) and of the underlying intima-media were measured, and the fibrinogen content per square centimeter of aorta wall was calculated relative to the radioactivity content of blood at exsanguination as described above.
Measurement of Prothrombin Time
After collection, blood samples were weighed (to determine the dilution due to ACD) and centrifuged (10 000 rpm, 2 minutes) to separate the plasma fraction. An automated plasma coagulation procedure described by Organon Technica, the supplier of Simplastin Excel (a form of thromboplastin), was used with a coagulation analyzer (Behring) to determine the prothrombin time for the ACD-plasma samples.
Morphology of the Platelet Layer
One-millimeter-thick, full-circumference rings of paraformaldehydefixed aorta wall were prepared for TEM as described previously. 2, 3 The samples were postfixed in buffered 1% osmium tetroxide for 1 hour, stained in 2% aqueous uranyl acetate for 1 hour, dehydrated through graded ethanol, and embedded in Spurr's resin. One-micrometer-thick sections, stained with toluidine blue, were examined by light microscopy, and areas showing maximal platelet accumulation with the luminal surface were selected for examination by TEM. Thin sections (60 to 90 nm), stained with lead citrate, were viewed on a Philips TEM 301 transmission electron microscope (Eindhoven, the Netherlands).
Statistical Calculations
When appropriate, data are given as the mean (ϮSEM). Data in Tables 1 and 2 were compared by ANOVA (QuattroPro version 7.0; one-way).
Results
Properties of 125 I-Fibrinogen
Rabbit 125 I-fibrinogen, as shown by SDS-PAGE (Fig 1) , consisted essentially of one single band, which barely entered the 7.5% polyacrylamide gel. After reduction by ␤-mercaptoethanol, the three component chains of fibrinogen, A␣, B␤, and ␥, appeared wholly separated as bands of M r estimated at 65 kD, 58 kD, and 56 kD, respectively. The Coomassiestained bands matched well with those of the autoradiograph (compare lane 1 with 2 and lane 3 with 4 in Fig 1) .
Effect of Ancrod on the Clearance of 125 I-Fibrinogen From the Rabbit Circulation
A three-dose regimen was used in the study of the effect of Ancrod pretreatment of rabbits used for studying the behavior of 51 Cr-platelets after balloon-catheter injury (see below). Blood samples were taken before and at 6 hours after the start of Ancrod treatment. ELISAs of the fibrinogen content of the plasmas were performed in the presence of appropriate quantities of purified rabbit fibrinogen on the same 96-well plates, and corrections were made for ACD content (Fig 2a) . From the ELISAs, plasma fibrinogen levels in the Ancrodtreated rabbits was Ϸ37% of that in normal rabbits. However, as shown by the immunoblot in Fig 2b, the polyspecific anti-fibrinogen antibody could not distinguish between intact fibrinogen and fibrinogen-related degradation products. Densitometric measurements of similar immunoblots of plasmas taken from five rabbits before and at 6 hours after Ancrod treatment showed that the content of intact fibrinogen in plasma before Ancrod treatment ranged from 91.0% to 99.8% (mean: 95.0Ϯ1.7%) of all stained bands, whereas "intact" fibrinogen in plasma at 6 hours after Ancrod treatment amounted to 38.0Ϯ0.6%. Thus, the plasma level of intact fibrinogen in plasma at 6 hours after starting the three-dose regimen of Ancrod treatment is calculated to be Ϸ14% of normal plasma levels (ie, 38% of 37% of normal plasma level), equal to Ϸ1 mol/L. Data (ϮSE) are compared with the fibrinogen (as 125 I-fibrinogen) content per milliliter of blood taken at exsanguination (ie, 10 minutes after injury). The low and high doses of r-hirudin were 1.2 (Ϯ0.1) and 5.0 (Ϯ0.2) mg/kg, respectively. The excised aorta was processed as described in "Methods." *PϽ.05; †PϽ.025; and ‡PϽ.01, calculated (ANOVA; one-way) for anticoagulant-treated versus saline-treated after balloon-catheter injury. Data (ϮSE) were calculated from the 51 Cr radioactivity content of the cellulose acetate (CA)-adsorbed layer and the intima-media (IM) layer of the aorta wall, knowing the specific 51 Cr radioactivity of the injected platelet preparation, the 51 Cr radioactivity per milliliter of blood taken at exsanguination (ie, 10 minutes after injury), and the total platelet content per milliliter of blood taken immediately before balloon-catheter or sham injury. The low and high doses of r-hirudin were 1.2 (Ϯ0.1) and 5.0 (Ϯ0.2) mg/kg, respectively. The excised aorta was divided into 1-cm segments and processed as described in "Methods." The
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Cr radioactivity in the intima-media layer was converted to platelet equivalents by using the known specific radioactivity. *PϽ.05; †PϽ.025, calculated (ANOVA; one-way) for anticoagulant-treated versus saline-treated after balloon-catheter injury. Measurements of platelet levels indicated that at 6 hours after the start of Ancrod treatment, the platelet level (3.3Ϯ0.2ϫ10 11 /L) was insignificantly different from that before treatment (3.7Ϯ0.3ϫ10 11 /L).
Uptake of 51 Cr-Platelets and 125 I-Fibrinogen by the Surface of the Aorta Wall After a Deendothelializing Injury to Saline-Treated Rabbits
At 10 minutes after a balloon-catheter injury to the aorta of a saline-treated rabbit, the aortic surface contained an abundance of adsorbed platelets and fibrinogen, as determined by the 51 Cr-and 125 I radioactivity contents, relative to the aortic surface of the sham-operated rabbit. The platelets adsorbed by the deendothelialized aortas of eight rabbits amounted to a mean of 222 800/mm 2 ( Table 1) . By contrast, platelets adsorbed by the aorta surface in the sham-injured rabbit (ie, the endothelium) amounted to 768/mm 2 . The fibrin(ogen) content of the platelet layer was calculated to be 5.3 pmol/cm 2 in aortas from balloon-injured rabbits, and 0.7 pmol/cm 2 with the aortic endothelium of sham-injured rabbits (Table 2) .
After the platelet layer was removed, the underlying subendothelium (isolated as the intima-media layer) was found to contain significant quantities of 51 Cr and 125 I radioactivities. As the platelet layer had been cleanly removed by cellulose acetate paper 8 and the specific radioactivity of the 51 Cr-labeled platelet preparation was known, the 51 Cr data were calculated as "platelet equivalents" per square millimeter, ie, the number of platelets equivalent to the measured 51 Cr radioactivity per square millimeter. The intima-media layer of the eight balloon-injured aortas contained Ϸ237 000 platelet equivalents per square millimeter in contrast to 616/mm 2 determined for that of the sham-injured aortas ( Table 1) . The mean fibrin(ogen) content of the balloon-injured aortas amounted to 16.9 pmol/cm 2 , in contrast to 0.4 pmol/cm 2 of sham-injured aorta ( Table 2) .
Effect of Pretreatment with r-Hirudin on Uptake of 51 Cr-Platelets and 125 I-Fibrinogen by the Aorta Wall After a Deendothelializing Injury
Deendothelialized aortas from r-hirudin-treated rabbits contained significantly fewer adsorbed platelets compared to those from saline-treated rabbits, decreasing to Ϸ121 000/ mm 2 (ie, 55% of the value measured for saline-injected, ballooned aortas) in rabbits pretreated with low dose, and to 53 000/mm 2 (24%) in rabbits pretreated with high dose of r-hirudin (Table 1) . Fibrin(ogen) deposition in the platelet layer was similarly decreased to 2.0 pmol/cm 2 (38% of the saline-injected ballooned aorta) and 0.9 pmol/cm 2 (17%) in the low-and high-dose r-hirudin-treated rabbits, respectively ( Table 2) .
Compared with aortas from saline-treated rabbits, the platelet equivalents per square millimeter of intima-media from ballooned aortas of low-and high-dose rabbits was decreased significantly to Ϸ41 000 (17% of the salineinjected, ballooned aorta) and 16 000 (7%), respectively (Table 1) . Fibrin(ogen) associated with the intima-media layer (6.7 and 6.4 pmol/cm 2 ) of low-and high-dose rabbits was decreased significantly to 40% and 38%, respectively, of the values measured for the intima-media from saline-treated rabbits (Table 2) . Compared with the low dose, the use of a high dose of r-hirudin did not significantly decrease further the uptake of fibrinogen by the deendothelialized aorta.
Effect of Pretreatment With Ancrod on the Uptake of 51 Cr-Platelets by the Aorta Wall After a Deendothelializing Injury
The plasma levels of fibrinogen were reduced by Ancrod treatment to Ϸ14% of normal plasma fibrinogen at the time of balloon-catheter treatment. In parallel, the adsorption of platelets by the exposed subendothelium was decreased significantly to 24% of the value measured for the salinetreated, ballooned rabbits, ie, from 222 800/mm 2 (salinetreated) to 52 700/mm 2 ( Table 1) . After removal of the platelet layer, the platelet equivalents associated with the underlying intima-media had decreased to Ϸ15 400/mm 2 , Ϸ7% of the value for saline-injected, ballooned aortas.
The effect of injecting r-hirudin into Ancrod-treated rabbits decreased the deposition of platelets on the ballooned aorta subendothelium to Ϸ42 000/mm 2 , which is 19% of the mean value determined for saline-injected ballooned aortas (Table  1) . This decrease was similar to that observed with either Ancrod alone or high-dose r-hirudin alone. However, the platelet equivalents associated with the intima-media layer decreased to Ϸ8800/mm 2 (3.7%) in the Ancrod/r-hirudintreated rabbits, a value substantially less than that in either Ancrod or low-dose r-hirudin pretreatments. Effect of Ancrod (Arvin) treatment on plasma fibrinogen levels in the rabbit. Rabbits were given Ancrod intravenously (1 U/kg) at time 0, a second dose (1 U/kg) after 1 hour, and a third dose (2 U/kg) at 2 hours. Blood samples (into ACD) were taken at 6 hours for measurement of plasma fibrinogen. a, Results of ELISA; various concentrations of purified rabbit fibrinogen were included as a standard on all 96-well plates; results for each plasma (nϭ7 Ancrod-treated rabbits; 5 control rabbits) were compared with the fibrinogen standard for that plate. b, Immunoblot of rabbit plasma fibrinogen. Plasmas before Ancrod treatment (control) and at 6 hours after Ancrod treatment were separated by SDS-PAGE (nonreducing conditions) and blotted to Immobilon. Blots were developed as described in the text and all stained bands quantified by densitometry.
Effect of Pretreatment With Warfarin on the Uptake of 51 Cr-Platelets and 125 I-Fibrinogen by the Aorta Wall After a Deendothelializing Injury
In four Warfarin-treated balloon-injured rabbits, platelet deposition on the surface of the deendothelialized aorta was decreased to 121 600/mm 2 (ie, 55%) and fibrin(ogen) to 1.4 pmol/cm 2 (26%) compared with aortas from saline-treated, balloon-injured rabbits (Tables 1 and 2) .
From the 51 Cr radioactivity, the platelet equivalents associated with the intima-media were decreased significantly in the Warfarin-pretreated rabbit to Ϸ30 000/mm 2 (ie, 12.5% of the saline-treated; Table 1 ). Fibrin(ogen) associated with the intima-media was decreased to 5.5 pmol/cm 2 (30%; Table 2 ).
Uptake of 125 I-Fibrinogen by the Deendothelialized Aorta Wall During Exsanguination
An intravenous dose of 125 I-fibrinogen was injected into nonanticoagulated rabbits at either 7, 8, or 9 minutes after inflicting a balloon (or sham) injury to quantify the fibrin(ogen) associated with the aorta surface (cellulose acetate layer) and underlying intima-media at 3 minutes, 2 minutes, and 1 minute before exsanguination (Fig 3) . These data allowed extrapolation to the time of the start of exsanguination so that the quantity of fibrin(ogen) deposited on and within the aorta wall during the exsanguination process could be assessed. Compared with the fibrin(ogen) content at 10 minutes after balloon injury (ie, 5.3 pmol/cm 2 of platelet layer; 16.9 pmol/cm 2 of intima-media; Table 2 ), the accumulation of fibrin(ogen) by the platelet layer (amounting to Ͻ5% of the total fibrinogen) and by the intima-media (Ͻ10%) of the aorta wall during exsanguination was considered to be negligible.
From the slope of each curve (Fig 3) and the mean level of fibrin(ogen) saturation from the data in Table 2 , the rates of turnover of fibrin(ogen) at the platelet layer and the intimamedia were estimated to be Ϸ6 minutes and Ϸ10 minutes, respectively, during the 10-minute interval after injury.
Assessment of the Luminal Surface of Aortas using TEM
The quantitative measurements of fibrin(ogen) and platelet adsorption by the sham-and balloon-injured aorta surface were supported by TEM inspection of the fourth segment from each aorta (Fig 4a through 4d) . The luminal surfaces of aortas from sham-injured rabbits were essentially devoid of platelets associated with the endothelium (data not shown).
Platelets accumulated in deposits ranging in depth from Ͻ5 to Ͼ20 platelets on the deendothelialized aortas from salinetreated rabbits (Fig 4a) . The platelets adsorbed directly to the subendothelium were invariably degranulated and spread. As the depth of platelets increased, platelets were more rounded and less shape changed as their distance from the aorta wall increased. Polymerized fibrin with a periodicity of Ϸ25 nm (see inset , Fig 4a) was seen filling the interplatelet spaces. By contrast, platelets adsorbed to ballooned aortas from hirudintreated (5 mg/kg) rabbits were comparatively sparse, the deendothelialized aortic surface covered generally with only a monolayer of shape-changed, vacuolated, and spread platelets adhering closely to the exposed subendothelium (Fig 4b) . The luminal surfaces of the ballooned aortas of Ancrodtreated rabbits (Fig 4c) , Warfarin-treated rabbits (Fig 4d) , and Ancrod/r-hirudin-treated rabbits (data not shown) after balloon-catheter injury were similar in appearance to those from r-hirudin-treated rabbits with respect to the platelet layer.
Discussion
The present data support evidence that thrombin, generated spontaneously at or within the exposed aortic subendothelium after injury, is involved directly with the rapid deposition of fibrin(ogen) and platelets on the exposed surface of the subendothelium in vivo (Fig 4a) ; evidence of polymerized fibrin with a periodicity of 25 nm 27 was frequently observed between aggregated platelets (Fig 4a, inset) . We also conclude that pretreatment with various anticoagulants that either inhibited thrombin production or activity or fibrin(ogen) deposition reduced substantially the accumulation of aggregated platelets and associated fibrin(ogen) at the surface of the exposed subendothelium. Thus, pretreatment of the rabbit with r-hirudin led to a parallel decrease in the quantities of adsorbed fibrinogen and platelets in the platelet layer (Tables  1 and 2 ), the higher dose of r-hirudin (5 mg/kg) reducing the uptake of fibrinogen by Ϸ70% and platelets by 80%. Kelly et al 28 reported a similar dose-dependent effect of r-hirudin on platelet deposition on endarterectomized aortic tissue and on platelet and fibrin deposition on collagen-coated tubing when used as arteriovenous shunts in baboons. We conclude that the deposition of fibrin(ogen) and the deposition of platelets after endothelial injury are not independent events. 125 I-fibrinogen was injected at 1, 2, or 3 minutes before exsanguination was commenced. In all rabbits, the total interval between balloon (or sham) injury and exsanguination was 10 minutes. After exsanguination, the aorta was excised and the radioactivity content of each 1-cm segment of aorta measured as described. The quantity of 125 I-fibrinogen bound by 1 cm 2 of cellulose acetate layer (sham, OE; ballooned, F) and intima-media layer (sham, ࡗ; ballooned, f) was compared with that present in 1 mL of blood at exsanguination. Fibrinogen concentration was calculated assuming that rabbit blood contains 3.58 mol of fibrinogen per liter. 19 Where SEM is shown, nϭ4 or 5 rabbits; results for the sham are from individual rabbits.
The fact that Warfarin treatment also caused a decrease in fibrinogen and platelet uptake after injury further strengthens the concept that thrombin plays a pivotal role in recruiting fibrinogen and platelets to the wound site. Warfarin acts as a vitamin K antagonist in vivo, inhibiting the synthesis of biologically active, vitamin K-dependent coagulation factors, such as factors VII, IX, X, and prothrombin. 29 From ELISA measurements of plasma samples taken before treatment and on day 4 or 5 since the start of treatment, Warfarin induced a sharp decline in rabbit plasma prothrombin concentration from 1.8 mol/L to Ϸ0.2 to 0.3 mol/L (A. Parshad and M.W.C. Hatton, unpublished data, 1996) . From this information and our knowledge of the fractional distribution of prothrombin in the rabbit, 9 we conclude that Warfarin causes the plasma prothrombin concentration, and consequently the resident concentration of prothrombin within the extracellular space of the aortic intima-media, to be decreased by up to 10-fold. This depleted reserve of prothrombin (and, presumably, of factors VII, IX, and X) within the intima-media may be insufficient to provide an adequate concentration of thrombin during the crucial first few minutes after injury, and the compromised plasma levels of these vitamin K-dependent factors would be inadequate to provide a sufficient flux to meet the prothrombinase requirement within the injured intima-media.
The similar effect of hirudin and Warfarin on the behaviors of fibrinogen and platelets toward the aorta wall after balloon injury suggests strongly that most of the platelet and fibrin(ogen) deposition is linked directly with thrombin production at the wound site. Why, then, should pretreatment with Ancrod, a snake-venom protease, which selectively depletes plasma fibrinogen 30 and which does not affect the plasma levels of prothrombin or other vitamin K-dependent factors in vivo or interfere with thrombin activation, 31 decrease platelet accumulation at the deendothelialized aorta wall (Table 1, Fig 4c) to a monolayer similar to the effect of r-hirudin? Ancrod cleaves the A␣ chain of mammalian fibrinogens, releasing only fibrinopeptide A to yield des-A-fibrinogen (or Ancrod-fibrin monomer). 32 In vitro, des-A-fibrinogen polymerizes poorly compared with thrombin-derived fibrin monomer, 33, 34 and, for this reason, Ancrod-fibrin clots are believed to be . Each rabbit was exsanguinated at 10 minutes after balloon-catheter injury was induced and the aorta excised and processed as described in the text. Segment 4 was placed in 4% paraformaldehyde for TEM. In the ballooned aorta from saline-treated rabbits (a), a layer of platelets (P) (ranging in thickness from Ͻ5 to Ͼ20 platelets) covered the subendothelium. Evidence of smooth muscle cell damage was seen within the intima and superficial media. Polymerized fibrin (F), with a periodicity of 25 nm (inset), was observed occupying the interplatelet space above the monolayer. By contrast, in the r-hirudin-, Ancrod-, and Warfarin-anticoagulated rabbits, the ballooned aorta surface was covered by only one to three layers of platelets. IEL indicates internal elastic lamina. In a, barϭ2 m (inset, 100 nm); in b, c, and d, barϭ1 m.
relatively easily dispersed and cleared from the circulation. As a result, after 6 hours of Ancrod treatment (Fig 2) , the intact fibrinogen level measured Ϸ14% of the normal plasma level, a value similar to that previously reported in rabbits after 6 hours of Ancrod treatment. 35 We also observed that the platelet level had not changed significantly after 6 hours of Ancrod treatment.
The Ancrod results suggest that as much as 80% of the platelet deposit on the subendothelium is caused directly by codepositing fibrin(ogen) and therefore only indirectly by thrombin. If all platelet adsorption, including the monolayer, was attributed to thrombin, then further pretreatment of the Ancrod rabbit with r-hirudin would decrease platelet binding further. This result was not observed (see Table 1 ). We conclude that the initial monolayer of platelets is attracted to the exposed subendothelium independently of thrombin production. Subendothelium-associated collagen and other adhesive proteins (eg, fibronectin, laminin, or von Willebrand factor) have been implicated as binding sites for the monolayer of adherent platelets immediately after injury. 36 Furthermore, in the salinetreated rabbit, the mass of platelets that aggregate with platelets of the initial monolayer are associated with obvious fibrin (Fig  4a) , and therefore their presence is clearly dependent on thrombin (and hence fibrin) production at the site of injury. Presumably, the production rate of thrombin after injury corresponds directly with the extent of the injury and, in the presence of normal plasma levels of fibrinogen, stimulates an appropriate deposition of fibrin(ogen) and platelets. Ancrod pretreatment causes a significant decrease in the availability of thrombinderived fibrin for significant platelet aggregation to take place on the monolayer. We note that Chang and Huang 35 reported that the depletion of fibrinogen caused by Ancrod leads to a decreased platelet aggregation activity in rabbits. Possibly, subendothelium-adsorbed des-A-fibrinogen or other Ancrod-derived fibrinogen degradation products may directly inhibit platelet aggregation, or the polymerization of thrombin-derived fibrin, which promotes platelet aggregation, with the platelet monolayer. A similar suggestion to explain the effect of Ancrodinduced hypofibrinogenemia on platelet plug formation has been made previously by Daniel et al. 37 Previous measurements of the deposition of platelets after a deendothelializing injury to the rabbit thoracic aorta have claimed that 42 000 to 45 000 platelets per square millimeter of subendothelium are equivalent to a saturated monolayer of platelets. 2, 38 In their perfusion-fixation procedure, Groves et al 2 perfused heparin-injected balloon-injured rabbits, first with Locke-Ringer physiological fluid (100 mm Hg) until the perfusate was clear of red cells, followed by a 4% (wt/vol) glutaraldehyde solution for 1 to 2 minutes; the aorta was excised later. In the present study, we have used neither heparin nor a perfusion-fixation technique; rather, the rabbit was rapidly exsanguinated through a carotid cannula, the aorta exposed, briefly rinsed, and then excised and processed. We accept that our procedure to deendothelialize an aorta may conceivably cause greater medial damage and therefore greater thrombin generation than the technique of Groves et al. 2 This difference in technique probably accounts, in part, for the greater deposition of platelets on the deendothelialized aorta in this study and in another recent study 39 of platelet deposition on the exposed subendothelium surface. Arguably, the process of exsanguination and the accompanying decline in blood pressure, followed by a partial collapse of the thoracic aorta may have encouraged further platelet aggregation at the surface of the artery wall. However, as shown by experiment (Fig 3) , only a minor proportion (Ͻ5%) of the total fibrin(ogen) in the platelet layer was deposited during exsanguination. From this result, it follows that only a minor fraction of the platelet layer would be deposited during the exsanguination step. After inducing a deendothelializing injury to the rabbit iliac artery, Goldberg et al 40 discovered that a platelet ␣-granule-specific protein, platelet factor 4, was located in increasing quantity within the intima-media during the first 30 minutes, but was markedly diminished at 4 hours after injury. The authors concluded that platelets in contact with the denuded vessel release the contents of their ␣-granules into the subendothelial space. Later, in a study of human platelet interaction with 35 S-labeled extracellular matrix proteoglycan, Yahalom et al 41 discovered that heparitinase, a lysosomal enzyme, 42 was released from adherent platelets and degraded heparan sulfate chains within the matrix. From Table 1 , it appears that 51 Cr-labeled platelets of the platelet layer release a large proportion of their 51 Cr contents into the underlying intima-media layer, possibly as microparticles resulting from the interaction between platelets, thrombin, and exposed collagen. 43 We rule out the possibility that the 51 Cr in the intima-media is due to free 51 Cr, ie, not contained by platelets, as the quantity of 51 Cr associated with the intima-media from aortas of sham-injured rabbits or from anticoagulated, balloon-injured rabbits was much less than that of the intimamedia of saline-injected, balloon-injured rabbits. Indeed, Ͼ90% of 51 Cr deposited into the subendothelial space was inhibited by pretreatment with either r-hirudin, Ancrod, or Warfarin and Ͼ96% by the administration of r-hirudin to the Ancrod-treated rabbit. We also reject the possibility that a high proportion of residual platelets remain adsorbed to the subendothelium after Häutchen preparation, as a previous study 8 using scanning electron microscopy has indicated the platelet layer to be entirely removed by cellulose acetate paper.
We conclude, similar to Gast et al, 7 that direct adherence of a monolayer of platelets to the exposed subendothelium takes place rapidly after injury and independently of thrombin generation. However, as thrombin is generated during the first few minutes after injury, fibrinogen is drawn to the site of injury, interacting with subendothelium-bound thrombin and forming fibrin. Subendothelium-associated thrombin and fibrin then stimulate more platelets to interact and aggregate with the platelets that comprise the monolayer. The presence of anticoagulant conditions inhibits in part or completely the secondary stage of platelet deposition, which involves thrombin and fibrin.
